Literature DB >> 27159180

Long-term survival of patients with therapy-related myeloid neoplasms after allogeneic hematopoietic cell transplantation-more than just a myth.

S Mukherjee1, A T Gerds1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27159180     DOI： 10.1038/bmt.2016.121

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation.

Authors:  J Finke; C Schmoor; H Bertz; R Marks; R Wäsch; R Zeiser; B Hackanson
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

2.  Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Authors:  Lindsay M Morton; Graça M Dores; Margaret A Tucker; Clara J Kim; Kenan Onel; Ethel S Gilbert; Joseph F Fraumeni; Rochelle E Curtis
Journal:  Blood       Date:  2013-02-14       Impact factor: 22.113

3.  Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

Authors:  Rafael Bejar; Kristen E Stevenson; Bennett Caughey; R Coleman Lindsley; Brenton G Mar; Petar Stojanov; Gad Getz; David P Steensma; Jerome Ritz; Robert Soiffer; Joseph H Antin; Edwin Alyea; Philippe Armand; Vincent Ho; John Koreth; Donna Neuberg; Corey S Cutler; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2014-08-04       Impact factor: 44.544

4.  Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.

Authors:  Sudipto Mukherjee; Chandana A Reddy; Jay P Ciezki; May Abdel-Wahab; Ramon V Tiu; Edward Copelan; Anjali A Advani; Yogen Saunthararajah; Katarina Paulic; Sean Hobson; Jaroslaw P Maciejewski; Brian J Bolwell; Matt Kalaycio; Robert Dreicer; Eric A Klein; Mikkael A Sekeres
Journal:  J Natl Cancer Inst       Date:  2014-02-27       Impact factor: 13.506

5.  Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

Authors:  Nicolaus Kröger; Ronald Brand; Anja van Biezen; Axel Zander; Judith Dierlamm; Dietger Niederwieser; Agnès Devergie; Tapani Ruutu; Jackie Cornish; Per Ljungman; Alois Gratwohl; Catherine Cordonnier; Dietrich Beelen; Eric Deconinck; Argiris Symeonidis; Theo de Witte
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

Review 6.  Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Virginia M Klimek
Journal:  Curr Opin Hematol       Date:  2013-03       Impact factor: 3.284

7.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Authors:  Valentina Nardi; Karen M Winkfield; Chi Young Ok; Andrzej Niemierko; Michael J Kluk; Eyal C Attar; Guillermo Garcia-Manero; Sa A Wang; Robert P Hasserjian
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

8.  Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Mark R Litzow; Sergey Tarima; Waleska S Pérez; Brian J Bolwell; Mitchell S Cairo; Bruce M Camitta; Corey S Cutler; Marcos de Lima; John F Dipersio; Robert Peter Gale; Armand Keating; Hillard M Lazarus; Selina Luger; David I Marks; Richard T Maziarz; Philip L McCarthy; Marcelo C Pasquini; Gordon L Phillips; J Douglas Rizzo; Jorge Sierra; Martin S Tallman; Daniel J Weisdorf
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.